Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations

Caramori, G.; Romagnoli, M.; Casolari, P.; Bellettato, C.; Casoni, G.; Boschetto, P.; K. Fan Chung; Barnes, P.J.; Adcock, I.M.; Ciaccia, A.; Fabbri, L.M.; Papi, A.
April 2003
Thorax;Apr2003, Vol. 58 Issue 4, p348
Academic Journal
Background: Exacerbations represent an important feature of the clinical manifestation and natural history of chronic obstructive pulmonary disease (COPD). Nuclear Iocalisation of p65 is a signal of nuclear factor-κB (NF-κB) activation. A study was undertaken to evaluate whether NF-κB activation is modified in sputum cells during COPD exacerbations. Methods: Total and nuclear p65 immunoreactivity was measured by immunocytochemistry in the sputum cells of 11 smokers with moderate COPD during an exacerbation and after 6-8 weeks of clinical stability. Results: Total sputum cell count was significantly increased during exacerbations from a median (IQR) of 880 (510-1865) to 1914.5 (1065-3205) × 10³/ml (p<0.05). The main inflammatory cells in the sputum were neutrophils (83.2 (75.4-92.3)%) and macrophages (14.7 (2.6-21.6)%) and their relative proportion did not change during exacerbations. Nuclear staining for p65 was absent in sputum neutrophils, both during exacerbations and in the stable phase. In contrast, the percentage of macrophages expressing nuclear p65 increased significantly during exacerbations from a median (IQR) of 16 (7-24)% to 41.4 (6-69)% (p<0.05).


Related Articles

  • Macrophage enrichment from induced sputum. Sikkeland, Liv I. B.; Kongerud, Johny; Stangeland, Astrici M.; Haug, Terje; Alexis, Neil E.; Stangeland, Astrid M // Thorax;Jun2007, Vol. 62 Issue 6, p558 

    The article discusses a study which demonstrates the capability to isolate sputum macrophages in asthma patients, to advance our understanding of macrophage biology in the airways. The techniques for isolating and enriching macrophages in sputum were compared. The magnetic bead isolation...

  • Modulation of glutaredoxin in the lung and sputum of cigarette smokers and chronic obstructive pulmonary disease. Peltoniemi, Mirva J.; Rytilä, Paula H.; Harju, Terttu H.; Soini, Ylermi M.; Salmenkivi, Kaisa M.; Ruddock, Lloyd W.; Kinnula, Vuokko L. // Respiratory Research;2006, Vol. 7, p133 

    Background: One typical feature in chronic obstructive pulmonary disease (COPD) is the disturbance of the oxidant/antioxidant balance. Glutaredoxins (Grx) are thiol disulfide oxidoreductases with antioxidant capacity and catalytic functions closely associated with glutathione, the major small...

  • A Comparison of the Clinical and Induced Sputum Characteristics of Early- and Late-Onset Asthma. Rossall, Matthew; Cadden, Paul; Kolsum, Umme; Singh, Dave // Lung;Aug2012, Vol. 190 Issue 4, p459 

    Background: There are few studies describing the phenotype of late-onset asthma (LOA). We sought to investigate the clinical and induced sputum characteristics of patients with LOA. Methods: Nineteen patients with LOA diagnosed after the age of 40 years and 19 patients with early-onset asthma...

  • Effect of Yufeining (...) on Induced Sputum Interleukin-8 in Patients with Chronic Obstructive Pulmonary Disease at the Stable Phase. Hong Min-li; Yang Guo-zong; Chen Wen-xi; Gao Ling-yun; Cai Shao-hang; Dai Shun-zhen // Chinese Journal of Integrative Medicine;Sep2005, Vol. 11 Issue 3, p179 

    Objective: To evaluate the effect of Yufeining (...), a traditional Chinese medicine, on induced sputum interleukin-8 (IL-8) in patients with chronic obstructive pulmonary disease (COPD) at the stable phase. Methods: Thirty-six patients with COPD were divided into trial group (18 cases) and...

  • IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Bullens, Dominique M. A.; Truyen, Els; Coteur, Liesbeth; Dilissen, Ellen; Hellings, Peter W.; Dupont, Lieven J.; Ceuppens, Jan L. // Respiratory Research;2006, Vol. 7, p1 

    Background: The role of Th2 cells (producing interleukin (IL-)4, IL-5 and IL-13) in allergic asthma is well-defined. A distinct proinflammatory T cell lineage has recently been identified, called Th17 cells, producing IL-17A, a cytokine that induces CXCL8 (IL-8) and recruits neutrophils....

  • Human Neutrophil Peptides sputum levels in symptomatic smokers and COPD patients. PAONE, G.; CONTI, V.; LEONE, A.; SCHMID, G.; PUGLISI, G.; GIANNUNZIO, G.; TERZANO, C. // European Review for Medical & Pharmacological Sciences;2011, Vol. 15 Issue 5, p556 

    Background and Objectives: Human Neutrophil Peptides (HNP) are major neutrophils' products which may contribute to the airway inflammation and lung remodelling during chronic obstructive pulmonary disease (COPD). We aimed to assess whether HNP sputum concentrations could be used as indicators of...

  • A Microfluidic Platform for Evaluating Neutrophil Chemotaxis Induced by Sputum from COPD Patients. Wu, Jiandong; Hillier, Craig; Komenda, Paul; Lobato de Faria, Ricardo; Levin, David; Zhang, Michael; Lin, Francis // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Chronic Obstructive Pulmonary Disease (COPD) is a common lung disease characterized by breathing difficulty as a consequence of narrowed airways. Previous studies have shown that COPD is correlated with neutrophil infiltration into the airways through chemotactic migration. However, whether...

  • Innate Immune Responses Are Increased in Chronic Obstructive Pulmonary Disease. Baines, Katherine Joanne; Simpson, Jodie Louise; Gibson, Peter Gerard // PLoS ONE;2011, Vol. 6 Issue 3, p1 

    Background: Chronic obstructive pulmonary disease (COPD) is characterised by irreversible airflow obstruction, neutrophilic airway inflammation and chronic bacterial colonisation, however the role of the innate immune response in the pathogenesis of COPD remains unclear. Methods: Induced sputum...

  • Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD. Grootendorst, Diana C.; Gauw, Stefanie A.; Verhoosel, Renate M.; Sterk, Peter J.; Hospers, Jeannette J.; Bredenbröker, Dirk; Bethke, Thomas D.; Hiemstra, Pieter S.; Rabe, Klaus F. // Thorax;Dec2007, Vol. 62 Issue 12, p1081 

    Background: Roflumilast is a targeted oral once-daily administered phosphodiesterase 4 (PDE4) inhibitor with clinical efficacy in chronic obstructive pulmonary disease (COPD). Results from in vitro studies with roflumilast indicate that it has anti-inflammatory properties that may be applicable...


Read the Article


Sign out of this library

Other Topics